Pluristem Therapeutics Inc (PSTI)

[Auto1]

Prepare to be DISAPPOINTED!! Imo. See this as psti's early, deflected, expectation management. As has been long suspected, poor trial design, has led to poor enrollment and likely sub optimal results... Amateur leadership, data will be ripe with excuses... See the writing on the wall here:

Results of PSTI P3 trials will be:

Further evaluation needed: Therapeutic angiogenesis in the treatment of PAD https://vascularnews.com/further-evaluation-needed-therapeutic-angiogenesis-in-the-treatment-of-pad/